Is TRKUF or JNJ a better dividend investment in 2026?

TRKUF currently yields 25000.00% with a 5% 5-year dividend growth rate. JNJ yields 2.13% with 5.8% growth. The better choice depends on your goal: TRKUF offers higher current income.

What is the dividend yield difference between TRKUF and JNJ?

TRKUF has a forward dividend yield of 25000.00% ($2.00/share annually). JNJ yields 2.13% ($5.20/share annually). The yield gap is 24997.87 percentage points.

Home › Compare › TRKUF vs JNJ

TRKUF vs JNJ: Dividend Comparison 2026

TRKUF yields 25000.00% · JNJ yields 2.13%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 TRKUF wins by $481652020747103174656.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

TRKUF

● Live price

25000.00%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$481652020747103174656.00M

Annual income

$477,891,679,681,809,340,000,000,000.00

Full TRKUF calculator →

JNJ

Johnson & Johnson

● Live price

2.13%

Share price

$244.44

Annual div

$5.20

5Y div CAGR

28%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.3K

Annual income

$4,689.40

Full JNJ calculator →

Portfolio growth — TRKUF vs JNJ

📍 TRKUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	TRKUF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, TRKUF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

TRKUF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRKUF

Annual income on $10K today (after 15% tax)

$2,125,000.00/yr

After 10yr DRIP, annual income (after tax)

$406,207,927,729,537,960,000,000,000.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$180.82/yr

After 10yr DRIP, annual income (after tax)

$3,985.99/yr

At 15% tax rate, TRKUF beats the other by $406,207,927,729,537,960,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRKUF + JNJ for your $10,000?

TRKUF: 50%JNJ: 50%

100% JNJ50/50100% TRKUF

Portfolio after 10yr

$240826010373551587328.00M

Annual income

$238,945,839,840,904,670,000,000,000.00/yr

Blended yield

99.22%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TRKUF

No analyst data

Altman Z

-4.2

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

-6.4% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRKUF buys

JNJ buys

No recent congressional trades found for TRKUF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricTRKUFJNJ

Forward yield	25000.00% ✓	2.13%
Annual dividend / share	$2.00	$5.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	28% ✓
Portfolio after 10y	$481652020747103174656.00M ✓	$30.3K
Annual income after 10y	$477,891,679,681,809,340,000,000,000.00 ✓	$4,689.40
Total dividends collected	$481404327977371041792.00M ✓	$15.4K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: TRKUF vs JNJ ($10,000, DRIP)

Year	TRKUF Portfolio	TRKUF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$2,510,700	$2,500,000.00	$10,592	$272.30	+$2.50M → TRKUF
2	$589,298,599	$586,612,149.53	$11,289	$357.73	+$589.29M → TRKUF
3	$129,309,604,119	$128,679,054,618.90	$12,123	$472.89	+$129309.59M → TRKUF
4	$26,527,150,102,459	$26,388,788,826,051.22	$13,141	$629.86	+$26527150.09M → TRKUF
5	$5,087,743,001,217,608	$5,059,358,950,607,977.00	$14,408	$846.81	+$5087743001.20M → TRKUF
6	$912,316,496,169,531,500	$906,872,611,158,228,600.00	$16,021	$1,151.60	+$912316496169.52M → TRKUF
7	$152,954,929,371,424,950,000	$151,978,750,720,523,570,000.00	$18,122	$1,588.22	+$152954929371424.91M → TRKUF
8	$23,976,822,470,935,107,000,000	$23,813,160,696,507,682,000,000.00	$20,930	$2,228.20	+$23976822470935108.00M → TRKUF
9	$3,514,337,444,199,857,700,000,000	$3,488,682,244,155,957,000,000,000.00	$24,792	$3,191.91	+$3514337444199857664.00M → TRKUF
10	$481,652,020,747,103,200,000,000,000	$477,891,679,681,809,340,000,000,000.00	$30,274	$4,689.40	+$481652020747103174656.00M → TRKUF

TRKUF vs JNJ: Complete Analysis 2026

TRKUF — Stock

Tarku Resources Ltd. engages in the exploration of mineral resources in Quebec and Arizona. The company explores for gold, lead, zinc, silver, copper, manganese, nickel, and platinum group element deposits. It holds 100% interests in the Apollo project covering 96 claims with an area of 5,273 hectares; Admiral project comprising 78 claims with an area of 4,334 hectares; and Atlas project consisting of 74 claims with an area of 4,111 hectares located in Quebec. The company also holds 100% interests in the Richardson project covering 42 mining claims covering 2,319 hectares; and Bullion project comprising 26 mining claims covering 1,435 hectares situated in Chibougamau. Tarku Resources Ltd. is headquartered in Saskatoon, Canada.

Full TRKUF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →

📬

Get this TRKUF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRKUF vs SCHD TRKUF vs JEPI TRKUF vs O TRKUF vs KO TRKUF vs MAIN TRKUF vs ABBV TRKUF vs MRK TRKUF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.